These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10891890)

  • 1. Detection of membrane-bound tumor necrosis factor (TNF): an analysis of TNF-specific reagents.
    Gerspach J; Götz A; Zimmermann G; Kolle C; Böttinger H; Grell M
    Microsc Res Tech; 2000 Aug; 50(3):243-50. PubMed ID: 10891890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell density-dependent regulation of cell surface expression of two types of human tumor necrosis factor receptors and its effect on cellular response.
    Pocsik E; Mihalik R; Ali-Osman F; Aggarwal BB
    J Cell Biochem; 1994 Apr; 54(4):453-64. PubMed ID: 8014194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
    Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
    J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of membrane TNF-like activity by cell surface targeting and matrix metalloproteinase-mediated processing of a TNF prodrug.
    Gerspach J; Müller D; Münkel S; Selchow O; Nemeth J; Noack M; Petrul H; Menrad A; Wajant H; Pfizenmaier K
    Cell Death Differ; 2006 Feb; 13(2):273-84. PubMed ID: 16052236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions.
    Scallon BJ; Moore MA; Trinh H; Knight DM; Ghrayeb J
    Cytokine; 1995 Apr; 7(3):251-9. PubMed ID: 7640345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor.
    Deshayes F; Laprée G; Portier A; Richard Y; Pencalet P; Mahieu-Caputo D; Horellou P; Tsapis A
    Oncogene; 2004 Apr; 23(17):3005-12. PubMed ID: 14691452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice.
    Georgopoulos S; Plows D; Kollias G
    J Inflamm; 1996; 46(2):86-97. PubMed ID: 8734789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping and functional analysis of three murine IgG1 monoclonal antibodies to human tumor necrosis factor-alpha.
    Bloom JW; Bettencourt JD; Mitra G
    J Immunol; 1993 Sep; 151(5):2707-16. PubMed ID: 7689613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.
    Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K
    J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of human adrenomedullin (AM) and tumor necrosis factor alpha (TNF-alpha) receptors on human epithelial carcinoma (HeLa) cells. The role of AM secretion in tumor cell sensitivity.
    Drimal D; Drimal J; Drimal J
    Neoplasma; 2006; 53(2):144-9. PubMed ID: 16575470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative.
    Wajant H; Moosmayer D; Wüest T; Bartke T; Gerlach E; Schönherr U; Peters N; Scheurich P; Pfizenmaier K
    Oncogene; 2001 Jul; 20(30):4101-6. PubMed ID: 11494138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor.
    Wüest T; Gerlach E; Banerjee D; Gerspach J; Moosmayer D; Pfizenmaier K
    Oncogene; 2002 Jun; 21(27):4257-65. PubMed ID: 12082613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha (TNF) regulates the expression of ICAM-1 predominantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve.
    Schäfers M; Schmidt C; Vogel C; Toyka KV; Sommer C
    Acta Neuropathol; 2002 Aug; 104(2):197-205. PubMed ID: 12111363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
    Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B; Fan Z
    Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
    Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
    J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Takeda K; Kobata T; Yagita H; Okumura K; Azuma M; Nagai R
    J Pathol; 2001 Dec; 195(5):593-603. PubMed ID: 11745696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of proteoglycans as the APRIL-specific binding partners.
    Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
    J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
    Ishikawa E; Nakazawa M; Yoshinari M; Minami M
    J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.